FALLS CHURCH, Va., March 6, 2019 /PRNewswire-PRWeb/ -- OTC Regulation Latest Developments and Best Practices **An FDAnews
There are significant new developments in OTC products including OTC monograph reform legislation, draft guidance on innovation in OTC products, recent enforcement actions, and user fees.
Christine Kirk — an associate in the Food and Drug Group of Arnall Golden Gregory's healthcare practice — will discuss recent developments in OTC regulation and enforcement as well as key compliance topics. Attendees will learn about:
Attendees will come away with a deeper understanding of the recent developments in the OTC area.
Meet Your Presenter: Christine Kirk is an associate in the Food and Drug Group within Arnall Golden Gregory's Healthcare Practice, and focuses her regulatory compliance practice on food, drug, and device law. Ms. Kirk has several years of experience with FDA, where she worked in CDER's Office of Regulatory Policy (ORP). While at FDA, Ms. Kirk worked on a wide variety of matters, including regulations, guidance, citizen petitions, and policy development. Ms. Kirk also has experience in reviewing comments on proposed regulations and guidance.
Who Will Benefit:
Webinar Details: OTC Regulation Latest Developments and Best Practices **An FDAnews Webinar** Monday, March 18, 2019, 1:30 p.m. - 3:00 p.m. EDT http://www.fdanews.com/otcregulation
Tuition: $287 per site
Easy Ways to Register: Online: http://www.fdanews.com/otcregulation By phone: 888-838-5578 or 703-538-7600
About FDAnews: FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
Subscribe to our Free Newsletters!